Hyperbaric oxygen therapy improves the effects of systemic steroid therapy for sudden sensorineural hearing loss
- PMID: 39906861
- PMCID: PMC11791220
- DOI: 10.1016/j.heliyon.2025.e42025
Hyperbaric oxygen therapy improves the effects of systemic steroid therapy for sudden sensorineural hearing loss
Abstract
Objectives: This study aimed to investigate the therapeutic efficacy of combined hyperbaric oxygen therapy (HBOT) and steroid therapy in treating sudden sensorineural hearing loss (SSNHL).
Design: This retrospective analysis included 505 patients diagnosed with SSNHL from August 2017 to July 2022. The patients received either a systemic steroid (SS) alone or SS with HBOT. Hearing improvement was evaluated with pure-tone audiometry (PTA). Among the participants, 102 received SS + HBOT, whereas 403 were treated with SS alone.
Results: The SS + HBOT group demonstrated significantly better improvement in the PTA threshold averaged across four low frequencies (PTA4) scores (22.7 ± 23.5 vs. 16.2 ± 21.4, P = 0.007) and higher response rates (≥15 dB improvement) and significant response (≥25 dB improvement) (61.8 % vs. 44.4 %, P = 0.002; and 43.1 % vs. 22.6 %, P < 0.001, respectively) than the SS-alone group. HBOT is particularly effective in patients with hearing loss at lower frequencies. Patients treated with HBOT were 2.50 times more likely to achieve substantial hearing improvement. Patients receiving three HBOT sessions or initiating treatment within 11 days of diagnosis demonstrated optimal outcomes. Greater improvements were observed in patients with initial hearing loss of >50 dB and younger individuals.
Conclusions: HBOT improves the effectiveness of SS treatment in SSNHL, with notable benefits for younger patients and those with an initial hearing loss of >50 dB. HBOT exhibited more pronounced effects at lower frequencies. Initiating HBOT within 11 days of the SSNHL diagnosis is recommended, and a regimen of five sessions is indicated for optimal results.
Keywords: Hyperbaric oxygen therapy; Steroid; Sudden sensorineural hearing loss; Treatment.
© 2025 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
The Effectiveness of Salvage Hyperbaric Oxygen Therapy Following Combined Steroid Therapy for Refractory Sudden Sensorineural Hearing Loss.Ann Otol Rhinol Laryngol. 2024 Apr;133(4):400-405. doi: 10.1177/00034894231222692. Epub 2024 Jan 10. Ann Otol Rhinol Laryngol. 2024. PMID: 38197374
-
Evaluating hyperbaric oxygen therapy as an adjunct to corticosteroids in sudden sensorineural hearing loss: a systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2025 May 22. doi: 10.1007/s00405-025-09372-2. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 40405024 Review.
-
Clinical impact of hyperbaric oxygen therapy combined with steroid treatment for sudden sensorineural hearing loss: A case-control study.Laryngoscope Investig Otolaryngol. 2024 Jul 3;9(4):e1297. doi: 10.1002/lio2.1297. eCollection 2024 Aug. Laryngoscope Investig Otolaryngol. 2024. PMID: 38974601 Free PMC article.
-
Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss: a retrospective analysis of outcomes.Diving Hyperb Med. 2016 Sep;46(3):160-165. Diving Hyperb Med. 2016. PMID: 27723017
-
Hyperbaric Oxygen Therapy for Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2022 Jan 1;148(1):5-11. doi: 10.1001/jamaoto.2021.2685. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34709348 Free PMC article.
References
-
- Klein L., et al. Is sudden sensorineural hearing loss an otologic emergency? Evidence-based cutoff for optimal treatment initiation for sudden unilateral sensorineural hearing loss: a case series and meta-analyses. Otol. Neurotol. 2023;44(3):216–222. doi: 10.1097/MAO.0000000000003808. - DOI - PubMed
-
- Kleyn A.D. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol. 2009;32(5–6):407–429. doi: 10.3109/00016484409119921. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous